The effect of Dipeptidyl Peptidase 4 inhibitor on the insulin resistance in the Japanese patients with type 2 diabetes

The effect of Dipeptidyl Peptidase 4 inhibitor on the insulin resistance in the Japanese patients with type 2 diabetes - The effect of Dipeptidyl Peptidase 4 inhibitor on the insulin resistance in the Japanese patients with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046686

Enrollment

Registered

2022-01-21

Start date

2013-03-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

DPP4 inihibitor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: type 2 diabetes mellitus patient.

Exclusion criteria

Exclusion criteria: Type 1 diabetes mellitus, pancreatic disease, liver disease, renal failure, or those taking diabetogenic medications such as corticosteroids

Design outcomes

Primary

Measure	Time frame
Improvement of glucose infusion rate during euglycemic-hyperinsulinemic clamp and improvement of HbA1c and postprandial blood glucose.	—

Countries

Japan

Contacts

Public ContactTsuyoshi Okura

Tottori University Faculty of Medicine Endocrinology and Metabolism

ohkura@tottori-u.ac.jp0859386517

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026